I samband med och inför Världsdiabetesdagen 14/11 2020 (WDD) samverkade retinaspecialistläkar-gruppen i Sverige med WHO-IDF-EU-representant inför nedan skrift
Download
2020, xiii + 85 pages
ISBN 978 92 890 5532 1
This publication is available online.
This guide is designed for policy-makers, public health leaders and senior clinicians involved in planning, designing and implementing diabetic retinopathy screening programmes in the WHO European Region.
The purpose of screening is to identify people with diabetes who are at higher risk of developing sight-threatening diabetic retinopathy so that early treatment or intervention can be offered to reduce the incidence of vision impairment or blindness.
It demonstrates how the Wilson & Jungner principles apply to diabetic retinopathy screening, describes the pathway to follow and explains how to initiate new programmes or improve the effectiveness of those already existing. The guide forms part of WHO’s efforts to increase the effectiveness of screening programmes within the Region, maximizing benefits and minimizing harm.
Läs hela skriften som pdf utan lösenord
https://apps.who.int/iris/bitstream/handle/10665/336660/9789289055321-eng.pdf
Diabetic retinopathy, screening: a short guide. Increase e ectiveness, maximize bene ts and minimize harm
Abstract
This guide is designed for policy-makers, public health leaders and senior clinicians involved in planning, designing and implementing diabetic retinopathy screening programmes in the WHO European Region.
The purpose of screening is to identify people with diabetes who are at higher risk of developing sight-threatening diabetic retinopathy so that early treatment or intervention can be o ered to reduce the incidence of vision impairment orblindness. It demonstrates how the Wilson & Jungner principles apply to diabetic retinopathy screening, describesthe pathway to follow and explains how to initiate new programmes or improve the e ectiveness of those already existing.
The guide forms part of WHO’s e orts to increase the e ectiveness of screening programmes within the Region, maximizing bene ts and minimizing harm.
Läs hela skriften som pdf utan lösenord 90 sidor
https://apps.who.int/iris/bitstream/handle/10665/336660/9789289055321-eng.pdf
Nyhetsinfo
www red DiabetologNytt
